Filing Details

Accession Number:
0001127602-11-024977
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-09 15:26:09
Reporting Period:
2011-09-07
Filing Date:
2011-09-09
Accepted Time:
2011-09-09 14:26:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224662 A John Kraeutler 3471 River Hills Drive
Cincinnati OH 45244
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-07 22,156 $2.09 217,416 No 4 M Direct
Common Stock Disposition 2011-09-07 22,156 $18.18 195,260 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2011-09-07 22,156 $0.00 22,156 $2.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
74,703 2010-10-01 2011-09-30 No 4 M Direct
Footnotes
  1. Prices range from $18.17 per share to $18.20 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.